{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-011726","form_type":"8-K","ticker":"LPAA","cik":"0002015502","company_name":"Launch One Acquisition Corp.","filed_at":"2026-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.996759+00:00","generated_at":"2026-05-16T05:05:32.416827+00:00","sec_items":["1.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Launch One Acquisition terminates business combination with Minovia Therapeutics","bullets":["Mutual termination effective Jan 30, 2026; BCA originally signed June 25, 2025 and amended four times.","Each party released the others from all liabilities and damages related to the transaction documents.","Ancillary agreements (voting, lock-up, sponsor letter) automatically terminated concurrently.","SPAC and its sponsor intend to seek alternative ways to consummate an initial business combination."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-011726","json":"https://secwatch.observer/filing/0001213900-26-011726.json","markdown":"https://secwatch.observer/filing/0001213900-26-011726.md","text":"https://secwatch.observer/filing/0001213900-26-011726.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2015502/000121390026011726/0001213900-26-011726-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2015502/000121390026011726/ea0275409-8k425_launchone.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:05:32.416827+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a47cc42ad0a371e2d9dd4f7a87a0f34af5ddc0eb","claim":"Launch One Acquisition Corp. terminated Business Combination Agreement with Minovia Therapeutics Ltd. valued at Termination and Release Agreement entered into on January 30, 2026 mutually terminating the Business (effective 2026-01-30).","evidence_excerpt":"Item 1.02 Termination of a Material Definitive Agreement. As previously disclosed, Launch One Acquisition Corp. (the “ Company ”) entered into a Business Combination Agreement, dated as of June 25, 2025, as amended on August 12, 2025, September 4, 2025, September 26, 2025 and January 6, 2026 (collectively, the “ BCA ”) with (i) Launch One Sponsor LLC, a Delaware limited liability company, in the capacity as the SPAC Representative (as defined in the BCA) under the BCA (the “ SPAC Representative ”), (ii) Minovia Therapeutics Ltd., an Israeli company limited by shares (“ Minovia ”), (iii) Natalie Yivgi-Ohana, in the capacity as the Seller Representative (as defined in the BCA) under the BCA (the “ Seller Representative ”), (iv) Mito US One Ltd., an Israeli company limited by shares (“ Pubco ”), and (v) Mito Sub Israel Ltd., an Israeli company limited by shares and a wholly-owned subsidiary of Pubco (“ Company Merger Sub ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2015502/000121390026011726/0001213900-26-011726-index.htm","confidence":0.98,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Minovia Therapeutics Ltd."},{"label":"Value","value":"Termination and Release Agreement entered into on January 30, 2026 mutually terminating the Business"},{"label":"Effective","value":"2026-01-30"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}